Mesonephric-like adenocarcinoma of the ovary
暂无分享,去创建一个
[1] R. Murali,et al. Cytologic features of upper gynecologic tract adenocarcinomas exhibiting mesonephric‐like differentiation , 2019, Cancer cytopathology.
[2] N Montalvo,et al. Mesonephric adenocarcinoma of the cervix: a case report with a three-year follow-up, lung metastases, and next-generation sequencing analysis , 2019, Diagnostic Pathology.
[3] K. Hasegawa,et al. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report , 2019, Diagnostic Pathology.
[4] J. K. Schoolmeester,et al. Corded and hyalinized mesonephric-like adenocarcinoma of the uterine corpus: report of a case mimicking endometrioid carcinoma. , 2019, Human pathology.
[5] M. Nucci,et al. A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the Endometrium , 2019, The American journal of surgical pathology.
[6] B. Gilks,et al. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract , 2018, The American journal of surgical pathology.
[7] L. Macconaill,et al. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract , 2018, The American journal of surgical pathology.
[8] M. Nucci,et al. Mesonephric proliferations of the female genital tract. , 2017, Pathology.
[9] T. Krausz,et al. An Ovarian Adenocarcinoma With Combined Low-grade Serous and Mesonephric Morphologies Suggests a Müllerian Origin for Some Mesonephric Carcinomas , 2017, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[10] W. McCluggage,et al. Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma. , 2018, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[11] W. McCluggage,et al. Hormone receptor‐negative, thyroid transcription factor 1‐positive uterine and ovarian adenocarcinomas: report of a series of mesonephric‐like adenocarcinomas , 2016, Histopathology.
[12] L. Macconaill,et al. Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract , 2015, Modern Pathology.
[13] Y. Sajjad. Development of the genital ducts and external genitalia in the early human embryo , 2010, The journal of obstetrics and gynaecology research.
[14] B. Mellado,et al. Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus. , 2003, Gynecologic oncology.